Annual Total Debt
$6.17 M
-$81.58 M-92.97%
31 December 2023
Summary:
Ligand Pharmaceuticals Incorporated annual total debt is currently $6.17 million, with the most recent change of -$81.58 million (-92.97%) on 31 December 2023. During the last 3 years, it has fallen by -$450.25 million (-98.65%). LGND annual total debt is now -99.05% below its all-time high of $650.18 million, reached on 31 December 2019.LGND Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$7.36 M
-$226.00 K-2.98%
30 September 2024
Summary:
Ligand Pharmaceuticals Incorporated quarterly total debt is currently $7.36 million, with the most recent change of -$226.00 thousand (-2.98%) on 30 September 2024. Over the past year, it has increased by +$1.03 million (+16.24%). LGND quarterly total debt is now -99.10% below its all-time high of $815.98 million, reached on 30 September 2018.LGND Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LGND Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -93.0% | +16.2% |
| 3 y3 years | -98.7% | -97.8% |
| 5 y5 years | -99.0% | -98.8% |
LGND Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -98.7% | at low | -97.8% | +19.3% |
| 5 y | 5 years | -99.0% | at low | -98.9% | +19.3% |
| alltime | all time | -99.0% | -99.1% |
Ligand Pharmaceuticals Incorporated Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $7.36 M(-3.0%) |
| June 2024 | - | $7.58 M(+22.4%) |
| Mar 2024 | - | $6.19 M(+0.5%) |
| Dec 2023 | $6.17 M(-93.0%) | $6.17 M(-2.6%) |
| Sept 2023 | - | $6.33 M(-45.8%) |
| June 2023 | - | $11.67 M(-86.8%) |
| Mar 2023 | - | $88.68 M(+1.1%) |
| Dec 2022 | $87.75 M(-73.0%) | $87.75 M(-23.0%) |
| Sept 2022 | - | $113.89 M(-21.2%) |
| June 2022 | - | $144.61 M(-25.9%) |
| Mar 2022 | - | $195.20 M(-39.8%) |
| Dec 2021 | $324.39 M(-28.9%) | $324.39 M(-1.9%) |
| Sept 2021 | - | $330.58 M(+2.5%) |
| June 2021 | - | $322.41 M(-11.9%) |
| Mar 2021 | - | $366.00 M(-19.8%) |
| Dec 2020 | $456.41 M(-29.8%) | $456.41 M(-0.8%) |
| Sept 2020 | - | $459.92 M(-0.1%) |
| June 2020 | - | $460.58 M(+1.2%) |
| Mar 2020 | - | $455.15 M(-30.0%) |
| Dec 2019 | $650.18 M(+2.2%) | $650.18 M(+1.2%) |
| Sept 2019 | - | $642.39 M(-3.1%) |
| June 2019 | - | $662.77 M(+2.8%) |
| Mar 2019 | - | $644.93 M(+1.4%) |
| Dec 2018 | $636.30 M(+183.4%) | $636.30 M(-22.0%) |
| Sept 2018 | - | $815.98 M(+1.2%) |
| June 2018 | - | $806.28 M(+254.3%) |
| Mar 2018 | - | $227.55 M(+1.3%) |
| Dec 2017 | $224.53 M(+5.5%) | $224.53 M(+1.3%) |
| Sept 2017 | - | $221.56 M(+1.3%) |
| June 2017 | - | $218.63 M(+1.3%) |
| Mar 2017 | - | $215.75 M(+1.3%) |
| Dec 2016 | $212.91 M(+5.4%) | $212.91 M(+1.3%) |
| Sept 2016 | - | $210.12 M(+1.3%) |
| June 2016 | - | $207.36 M(+1.3%) |
| Mar 2016 | - | $204.65 M(+1.3%) |
| Dec 2015 | $201.99 M(+3.1%) | $201.99 M(-0.5%) |
| Sept 2015 | - | $202.95 M(+1.2%) |
| June 2015 | - | $200.57 M(+1.0%) |
| Mar 2015 | - | $198.57 M(+1.4%) |
| Dec 2014 | $195.91 M(+2050.7%) | $195.91 M(+1.0%) |
| Sept 2014 | - | $193.97 M(+7089.3%) |
| June 2014 | - | $2.70 M(-53.2%) |
| Mar 2014 | - | $5.77 M(-36.7%) |
| Dec 2013 | $9.11 M(-67.8%) | $9.11 M(-26.4%) |
| Sept 2013 | - | $12.38 M(-20.5%) |
| June 2013 | - | $15.57 M(-16.8%) |
| Mar 2013 | - | $18.71 M(-33.8%) |
| Dec 2012 | $28.28 M(-6.6%) | $28.28 M(-24.9%) |
| Sept 2012 | - | $37.67 M(-31.1%) |
| June 2012 | - | $54.68 M(+35.9%) |
| Mar 2012 | - | $40.25 M(+32.9%) |
| Dec 2011 | $30.29 M(>+9900.0%) | $30.29 M(-55.5%) |
| Sept 2011 | - | $68.02 M(+70.1%) |
| June 2011 | - | $39.98 M(-2.2%) |
| Mar 2011 | - | $40.88 M(>+9900.0%) |
| Dec 2010 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2010 | - | $43.69 M(-10.8%) |
| June 2010 | - | $48.99 M(+25.9%) |
| Mar 2010 | - | $38.91 M(+7.3%) |
| Dec 2009 | $36.27 M | $36.27 M(-36.9%) |
| Sept 2009 | - | $57.47 M(-0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | $57.93 M(-0.8%) |
| Mar 2009 | - | $58.41 M(+13.3%) |
| Dec 2008 | $51.53 M(+2291.2%) | $51.53 M(+5703.0%) |
| Sept 2008 | - | $888.00 K(-28.6%) |
| June 2008 | - | $1.24 M(-24.2%) |
| Mar 2008 | - | $1.64 M(-23.9%) |
| Dec 2007 | $2.15 M(-94.9%) | $2.15 M(-20.2%) |
| Sept 2007 | - | $2.70 M(-16.9%) |
| June 2007 | - | $3.25 M(-14.3%) |
| Mar 2007 | - | $3.79 M(-91.0%) |
| Dec 2006 | $42.07 M(-75.7%) | $42.07 M(-70.5%) |
| Sept 2006 | - | $142.43 M(-1.6%) |
| June 2006 | - | $144.82 M(-1.1%) |
| Mar 2006 | - | $146.45 M(-15.3%) |
| Dec 2005 | $172.92 M(-0.6%) | $172.92 M(-0.1%) |
| Sept 2005 | - | $173.02 M(-0.4%) |
| June 2005 | - | $173.80 M(-0.2%) |
| Mar 2005 | - | $174.09 M(+0.0%) |
| Dec 2004 | $174.02 M(+0.9%) | $174.02 M(-0.1%) |
| Sept 2004 | - | $174.19 M(+2.5%) |
| June 2004 | - | $170.01 M(-2.1%) |
| Mar 2004 | - | $173.59 M(+0.6%) |
| Dec 2003 | $172.53 M(+9.7%) | $172.53 M(+11.1%) |
| Sept 2003 | - | $155.25 M(-5.7%) |
| June 2003 | - | $164.67 M(+4.6%) |
| Mar 2003 | - | $157.35 M(+0.0%) |
| Dec 2002 | $157.34 M(+10.7%) | $157.34 M(+885.9%) |
| Sept 2002 | - | $15.96 M(+106.4%) |
| June 2002 | - | $7.73 M(-86.2%) |
| Mar 2002 | - | $56.01 M(-60.6%) |
| Dec 2001 | $142.13 M(+5.1%) | $142.13 M(+1.8%) |
| Sept 2001 | - | $139.61 M(-9.6%) |
| June 2001 | - | $154.41 M(+13.3%) |
| Mar 2001 | - | $136.33 M(+0.8%) |
| Dec 2000 | $135.18 M(-4.0%) | $135.18 M(+8.9%) |
| Sept 2000 | - | $124.10 M(+0.9%) |
| June 2000 | - | $122.97 M(+1.4%) |
| Mar 2000 | - | $121.33 M(-13.8%) |
| Dec 1999 | $140.80 M(+50.3%) | $140.80 M(-11.1%) |
| Sept 1999 | - | $158.30 M(+64.4%) |
| June 1999 | - | $96.30 M(+2.0%) |
| Mar 1999 | - | $94.40 M(+0.7%) |
| Dec 1998 | $93.70 M(+72.9%) | $93.70 M(+77.5%) |
| Sept 1998 | - | $52.80 M(+2.1%) |
| June 1998 | - | $51.70 M(-5.7%) |
| Mar 1998 | - | $54.80 M(+1.1%) |
| Dec 1997 | $54.20 M(-4.2%) | $54.20 M(+3.0%) |
| Sept 1997 | - | $52.60 M(-3.3%) |
| June 1997 | - | $54.40 M(+1.5%) |
| Mar 1997 | - | $53.60 M(-5.3%) |
| Dec 1996 | $56.60 M(+8.2%) | $56.60 M(+11.4%) |
| Sept 1996 | - | $50.80 M(-5.8%) |
| June 1996 | - | $53.90 M(+1.1%) |
| Mar 1996 | - | $53.30 M(+1.9%) |
| Dec 1995 | $52.30 M(+284.6%) | $52.30 M(+2.8%) |
| Sept 1995 | - | $50.90 M(>+9900.0%) |
| June 1995 | - | $0.00(-100.0%) |
| Mar 1995 | - | $13.30 M(-2.2%) |
| Dec 1994 | $13.60 M | $13.60 M(+0.7%) |
| Sept 1994 | - | $13.50 M(+285.7%) |
| June 1994 | - | $3.50 M(0.0%) |
| Mar 1994 | - | $3.50 M |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual total debt?
- What is the all time high annual total debt for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual total debt year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly total debt?
- What is the all time high quarterly total debt for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly total debt year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual total debt?
The current annual total debt of LGND is $6.17 M
What is the all time high annual total debt for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual total debt is $650.18 M
What is Ligand Pharmaceuticals Incorporated annual total debt year-on-year change?
Over the past year, LGND annual total debt has changed by -$81.58 M (-92.97%)
What is Ligand Pharmaceuticals Incorporated quarterly total debt?
The current quarterly total debt of LGND is $7.36 M
What is the all time high quarterly total debt for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly total debt is $815.98 M
What is Ligand Pharmaceuticals Incorporated quarterly total debt year-on-year change?
Over the past year, LGND quarterly total debt has changed by +$1.03 M (+16.24%)